Bogdan Vlacho

Post-doctoral researcher, Biomedical Network Research Center for Diabetes and Associated Metabolic Diseases (CIBERDEM: CB15/00071)

[Joan Caylà @JoanCayla]

Machine learning models for the prediction of #COVID-19 prognosis in the primary health care setting

👉 Predictors: age, epidemic wave, social deprivation, diabetes mellitus, obesity, COPD, cardiovascular disease, high blood pressure and dyslipidemia

https://t.co/XjnYvIhJ3K

[Hospital Clínic @hospitalclinic]

🫀 Un estudi del #CLÍNIC-@idibaps i l'@IDIAPJGol mostra que el risc de desenvolupar malalties cardiovasculars en persones amb #diabetis tipus 2 es duplica cada dècada que envelleixen

Han analitzat dades de 247.751 pacients amb un seguiment de 7️⃣ anys

👉 https://t.co/h6VhyKP1rj

[IDIAPJGol @IDIAPJGol]

A research from #IDIAPJGol and @CIBER led by researchers @angelsmollo & @VlachoBogdan evaluates the impact of a multicomponent intervention designed to improve glycemic control on blood pressure and lipids in people with type 2 diabetes in #PrimaryCare.

➡️https://t.co/LpNaIH3S3q

[IDIAPJGol @IDIAPJGol]

A research from #IDIAPJGol and @CIBER led by researchers @angelsmollo & @VlachoBogdan evaluates the impact of a multicomponent intervention designed to improve glycemic control on blood pressure and lipids in people with type 2 diabetes in #PrimaryCare.

➡️https://t.co/LpNaIH3S3q

[Dídac Mauricio @DidacMauricio]

We are glad to share a new paper on diabetic foot disease, published in Cardiovascular Diabetology
https://t.co/pP7ZwXLH3P
@kamleshkhunti @ciberdem @IRSantPau @xaviercos @dianatundi @manelmatacases @EndocrinoSPau

[CIBER ISCIII @CIBER_ISCIII]

🧬🔬 Varios grupos del @ciberdem , liderados por el @HospitalSantPau, han descubierto una significativa asociación de 54 lípidos con la diabetes tipo 1 y 2, diferenciada por sexo y estado glucémico. @CIBERBBN #Diabetes #CIBERDEM #Investigación

🔗Más : https://t.co/05cXu6TqBV

[Bogdan Vlacho @VlachoBogdan]

@IDIAPJGol @Pepbaga @manelbalcells @BoniBolbar @Wonkaworld @PilarAstier 👏🏻

[Bogdan Vlacho @VlachoBogdan]

Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study https://t.co/CPVB4dCtv7 #mdpijcm via @JCM_MDPI @josepfranch @DidacMauricio @angelsmollo

[Berta Soldevila @SoldevilaBerta]

Our last paper about prevalence of gestational diabetes in Catalonia using #sidiap data @DidacMauricio @josepfranch @xaviercos @MartadeMarte @LouAlpe #bogdanvlacho @ciberdem @IDIAPJGol @hgermanstrias @gede_diabetes

https://t.co/TbnsYC90wg

[PCDiabetesEurope @PCDEurope]

Meet the thought leaders in T2D management in PC community setting. Connect with your peers #PCDEconference in Barcelona,  6-8 June
REGISTER NOW for super early bird fee:https://t.co/J2rVP1gNYr
SUBMIT YOUR ABSTRACT: https://t.co/pkJ9s5PLMA
€1000 Best Abstract Award #pcdeurope

[Atenció Primària i a la Comunitat de l'ICS @primariaicscat]

El Grup de Recerca en Diabetis des de l'Atenció Primària (DAP_CAT) ha publicat un article a @DiabetesCareADA sobre la relació entre la reducció ràpida dels nivells de glucosa en sang i la progressió de la retinopatia diabètica lleu o moderada
#RecercaAPBCN
https://t.co/eWmEyvtpSu

[Gabriel Gimenez MD @ggimenezendocri]

Our contribution to the knowledge of cardiovascular events in type 1 diabetes
https://t.co/zXkdjHkny3
Thanks to @DidacMauricio, @EmilioOrtegaMdV and all the collaborators
@HospitalSantPau, @recercafphag , @ciberdem

[Dídac Mauricio @DidacMauricio]

Glad to share our latest article!

Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-World Population-Based Study in Subjects With Type 2 Diabetes https://t.co/bAWZPeKudV
@ciberdem @EndocrinoSPau @HospitalSantPau @EmilioOrtegaMdV @VlachoBogdan

[ARISTOS Postdoc @postdocAristos]

☀️ Join the ARISTOS Program in #Spain and experience fantastic working conditions for 3 years! Embrace the vibrant research culture, collaborate with top-notch scientists 👩‍🔬, and make significant contributions to the field of Biomedicine. Don't miss this opportunity!

[Xose R Bustelo @XRBustelo]

❎🔴👉 Are you interested in a good Marie-Curie-like posdoc position in our lab at the @CIBERONC and @CICancer_com in Salamanca (Spain)❓ This is an excellent opportunity. Take a look at the call‼️ @EACRnews @SmallGTPases @EMBO @ComunidadCeru @FASEBorg

[ARISTOS Postdoc @postdocAristos]

"Exciting news! 🚀 Join us for the #MSCA #ARISTOS #PostdocProgram kick-off meeting on July 13th at 3pm (UTC+2) Madrid time. Calling all interested candidates! Don't miss out!📢 We are waiting for you! Register in 🔗 https://t.co/fPVKNQuklh

[PCDiabetesEurope @PCDEurope]

Three more days to the 16th #PCDEurope23 conference in Barcelona. Join us via livestream and get your virtual registration here;https://t.co/sox67n4MQH Join the scientific sessions + sign up for symposia #PrimaryCare #Diabetes

[PCDiabetesEurope @PCDEurope]

🆕#PCDEurope23 is now HYBRID!!
Come and join us at the 1⃣6⃣th Int. #PrimaryCare #Diabetes Europe Conference ‼️
Take the opportunity to participate in the conference virtually. Choose the best format for you; virtual or in-person!
REGISTER HERE:
https://t.co/sqXZVvX9eb

[Dídac Mauricio @DidacMauricio]

A new tool to assess CV risk in type 2 diabetes. Glad to have been involved!

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe https://t.co/iWvdozci9i
@ciberdem @EndocrinoSPau @IIBSantPau @ugp_IDIAPJGol @manelmatacases @VlachoBogdan